HHS partners to develop COVID-19 immunotherapies; plasma donation encouraged
Collaborating with non-governmental organizations, the Department of Health and Human Services is working to develop convalescent plasma and hyperimmune globulin immunotherapies for COVID-19 patients. Both products use blood plasma from recovered patients, which contain SARS-CoV-2 antibodies that could stimulate the immune system for COVID-19 patients. Patients who have recovered from COVID-19 can learn more about donating plasma here.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…